← All reports
NASDAQ:PAX01/26/2026

Snowcap Research Short Report on PAX

By Snowcap ResearchView original source ↗
$15.98
Open on report
$10.8
Close on report
-32.39%
% since report
Full history, earnings & live data
Snowcap Research
January 2026 Short Report 69 Pages
Short Thesis

Patria Investments $PAX: Castle of Cards

A Brazilian alternative asset manager allegedly masking losses and overstating performance through aggressive valuations and off-balance sheet arrangements.

"This can trigger some big issues in terms of people don't trust or even like the LPs don't trust anymore the valuation and of course Patria will need to do some huge fundraising... I think it's like a waterfall, whenever you talk about trust. Right so when people don't trust the assets anymore everything falls."

— Former Patria Executive
Total AUM
~$50B
PE Fund IV DPI
27%
Elfa Bonds Price
50¢/$
Top Holding Conc.
52%+ NAV
Premium to Peers
Up to 500%
Blackstone Exit
40% Stake
PE Fund IV Age
16 Years
Investment Thesis

Patria Investments is a Brazilian alternative asset manager that may be overstating performance and masking losses within its flagship private equity and infrastructure funds through aggressive private valuations and off-balance sheet financing structures.

Brazilian fund filings reveal that many of Patria's key investments are cash-burning or financially distressed, yet continue to be valued at extreme premiums to listed peers—in some cases exceeding 500%. The firm has propped up flailing investments with off-balance-sheet loans and fund-level guarantees, delaying loss recognition while increasing LP exposure.

Key Red Flags
📊
Extreme Valuation Premiums
Key holdings marked at 15-34x EV/EBITDA vs public peers trading at 4-8x. Elfa valued at 15.6x despite bonds trading at 50¢ on the dollar.
💀
Distressed Portfolio Companies
Elfa underwent debt restructuring; Athena missed EBITDA targets by 42%; Superfrio widening losses; Essentia required R$655M recapitalization.
🏦
Off-Balance Sheet Financing
R$1bn+ emergency capital injected into Elfa via SPV debt structures. Fund-level guarantees increase LP exposure while hiding distress.
🔄
Circular Transactions
Nearly all FY24 performance fees came from transferring a half-built desalination plant between Patria's own infrastructure funds.
📝
Exit Misrepresentation
Patria claimed Delly's exit was "at mark," but Brazilian filings reveal a 20% discount. Undermines valuation credibility.
⚠️
Governance Concerns
CFO resigned following unexplained auditor change in 2025. Former executive describes turnover as "huge" citing internal disagreement.
Valuation Analysis

EV/EBITDA: Patria Marks vs. Listed Peers

Elfa Medicamentos
15.6x
Patria
6.4x
Peers
Athena Saude
33.9x
Patria
6.2x
Peers
Essentia Energia
18.5x
Patria
7.7x
Peers
Grupo H (Saude Latam)
16.9x
Patria
5.4x
Peers
Superfrio
14.2x
Patria
9.9x
Peers
Realization Performance

Capital Returned to LPs (% of NAV)

PE Fund III (2007) 100%
Fully Realized
PE Fund IV (2011) — 16 Years Old 27%
27%
PE Fund V (2015) — 11 Years Old 21%
21%
Infra Fund III (2013) 80%
80%
Infra Fund IV (2018) 1%
1%
Exit Quality Analysis
Exit Since IPO Nature Assessment
Aguas Pacifico Sold to Patria Fund VI ✗ Internal Transfer
Delly's Sold to Patria Fund VII + CVC ✗ Internal + 20% Discount
Hidrovias Sold to Ultrapar (minority holding) ✗ Related Party
Lavoro SPAC Merger ✗ Stock Down 90%
ODATA Sold to Aligned ✓ Third-Party Sale
SmartFit IPO ✓ Public Market Exit
Entrevias Sold 55% to Vinci ✓ Third-Party Sale
Snowcap Research Conclusion

A "Castle of Cards" Built on Overstated Valuations

▼ Short Position

Snowcap believes Patria has buried problems in its key funds because it knows they are potentially terminal to its track record and franchise value. Even conservative assumptions around the fair value of these investments suggests Patria may have hugely overstated fund performance and is potentially masking investor losses. At a 3.5% dividend yield, the valuation appears stretched given elevated Brazilian macro risk (Selic ~15%), uncertain dividend sustainability, and a lackluster track record for EPS growth.

📉
Valuation Write-Downs
Key holdings marked at 3-5x public peer multiples. Downside to equity value ranges from 54% to 100%.
💸
Dividend Pressure
May need to cut dividend again to meet $187M+ near-term deferred M&A obligations.
🏚️
AUM Roll-Off Risk
40% of AUM may mature or roll off within 3 years. Company stopped disclosing duration data.
🇧🇷
LatAm PE Challenges
Region abandoned by marquee PE firms. Selic at ~15%, recent corporate default wave in Brazil.
🔄
Fundraising Sustainability
Recent raises propped up by own vehicles and alleged LP prepayments. Internal demand overstated.
⚖️
LP Trust Erosion
Former exec: "Whenever you talk about trust... when people don't trust the assets anymore everything falls."
Disclaimer: This research report expresses solely the biased opinions of Snowcap Advisors UK Ltd ("Snowcap"). Snowcap has a short interest in Patria's stock and stands to realize significant gains in the event that the price of such securities declines. Snowcap reserves the right to change or modify any of its opinions expressed herein at any time and for any reason. This presentation and its contents are not intended to be and do not constitute or contain any financial product advice. Investors should seek their own financial, legal and tax advice in respect of any decision regarding any securities discussed herein. You should do your own research and due diligence before making any investment decisions. All information is based on publicly available sources; Snowcap makes no representation that misconduct, fraud, or illegality has occurred. Past performance is not indicative of future results.